DHRS2 mediates cell growth inhibition induced by Trichothecin in nasopharyngeal carcinoma
暂无分享,去创建一个
Xiangjian Luo | Ya Cao | Jikai Liu | Zhijie Xu | J. Quan | Can Cheng | Chaoliang Liao | Xu Zhao | Namei Li | Runxin Ye
[1] A. Bode,et al. Posttranslational regulation of PGC‐1α and its implication in cancer metabolism , 2019, International journal of cancer.
[2] M. Skowron,et al. Deciphering the molecular effects of romidepsin on germ cell tumours: DHRS2 is involved in cell cycle arrest but not apoptosis or induction of romidepsin effectors , 2018, Journal of cellular and molecular medicine.
[3] Xiangjian Luo,et al. The implications of signaling lipids in cancer metastasis , 2018, Experimental & Molecular Medicine.
[4] Xiang-Hua Wang,et al. Novel natural compounds from endophytic fungi with anticancer activity. , 2018, European journal of medicinal chemistry.
[5] A. Bode,et al. Wild-type IDH2 promotes the Warburg effect and tumor growth through HIF1α in lung cancer , 2018, Theranostics.
[6] Yang Han,et al. HOXA13 contributes to gastric carcinogenesis through DHRS2 interacting with MDM2 and confers 5‐FU resistance by a p53‐dependent pathway , 2018, Molecular carcinogenesis.
[7] A. Bode,et al. DNMT1 mediates metabolic reprogramming induced by Epstein–Barr virus latent membrane protein 1 and reversed by grifolin in nasopharyngeal carcinoma , 2018, Cell Death & Disease.
[8] A. Nakai,et al. Acute HSF1 depletion induces cellular senescence through the MDM2-p53-p21 pathway in human diploid fibroblasts , 2018, Journal of Cell Science.
[9] J. Onuchic,et al. Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy , 2018, Theranostics.
[10] A. Čumová,et al. Natural compounds and combination therapy in colorectal cancer treatment. , 2018, European journal of medicinal chemistry.
[11] X. Ban,et al. DHRS2 inhibits cell growth and motility in esophageal squamous cell carcinoma , 2017, Oncogene.
[12] Xiangjian Luo,et al. Emerging roles of lipid metabolism in cancer metastasis , 2017, Molecular Cancer.
[13] D. Adelson,et al. Understanding the Effectiveness of Natural Compound Mixtures in Cancer through Their Molecular Mode of Action , 2017, International journal of molecular sciences.
[14] Simion I. Chiosea,et al. Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations , 2017, Nature Communications.
[15] D. Herr,et al. Aberrant expression of the S1P regulating enzymes, SPHK1 and SGPL1, contributes to a migratory phenotype in OSCC mediated through S1PR2 , 2016, Scientific Reports.
[16] Liming Jin,et al. Potential Pharmacological Resources: Natural Bioactive Compounds from Marine-Derived Fungi , 2016, Marine drugs.
[17] Edwin P Hui,et al. Nasopharyngeal carcinoma , 2016, The Lancet.
[18] D. Newman,et al. Natural Products as Sources of New Drugs from 1981 to 2014. , 2016, Journal of natural products.
[19] J. Medema,et al. Betulinic acid induces a novel cell death pathway that depends on cardiolipin modification , 2016, Oncogene.
[20] S. Beloribi-Djefaflia,et al. Lipid metabolic reprogramming in cancer cells , 2016, Oncogenesis.
[21] M. Jia,et al. Endophytic fungi with antitumor activities: Their occurrence and anticancer compounds , 2014, Critical reviews in microbiology.
[22] Fei-Fei Liu,et al. Nasopharyngeal Cancer: Molecular Landscape. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] Xiangjian Luo,et al. The role of targeting kinase activity by natural products in cancer chemoprevention and chemotherapy (Review). , 2015, Oncology reports.
[24] Lunzhao Yi,et al. A metabolic discrimination model for nasopharyngeal carcinoma and its potential role in the therapeutic evaluation of radiotherapy , 2013, Metabolomics.
[25] Robert V Farese,et al. Cellular fatty acid metabolism and cancer. , 2013, Cell metabolism.
[26] Jochen Gaedcke,et al. Integration of Metabolomics and Transcriptomics Revealed a Fatty Acid Network Exerting Growth Inhibitory Effects in Human Pancreatic Cancer , 2013, Clinical Cancer Research.
[27] Yan Li,et al. Trichothecin Induces Cell Death in NF-κB Constitutively Activated Human Cancer Cells via Inhibition of IKKβ Phosphorylation , 2013, PloS one.
[28] S. Akman,et al. Fatty Acid Metabolites in Rapidly Proliferating Breast Cancer , 2013, PloS one.
[29] S. Fischer,et al. Changes in Cancer Cell Metabolism Revealed by Direct Sample Analysis with MALDI Mass Spectrometry , 2013, PloS one.
[30] A. Harris,et al. How cancer metabolism is tuned for proliferation and vulnerable to disruption , 2012, Nature.
[31] J. Dumont,et al. Metabolic reprogramming of the tumor , 2012, Oncogene.
[32] Claudio R. Santos,et al. Lipid metabolism in cancer , 2012, The FEBS journal.
[33] K. To,et al. Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches. , 2012, Seminars in cancer biology.
[34] R. Deberardinis,et al. Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us? , 2012, Cell.
[35] David J Newman,et al. Natural products as sources of new drugs over the 30 years from 1981 to 2010. , 2012, Journal of natural products.
[36] R. Tan,et al. Trichothecin induces apoptosis of HepG2 cells via caspase-9 mediated activation of the mitochondrial death pathway. , 2012, Toxicon : official journal of the International Society on Toxinology.
[37] A. Conesa,et al. Differential expression in RNA-seq: a matter of depth. , 2011, Genome research.
[38] Guohong Li,et al. Endophytic fungus Trichothecium roseum LZ93 antagonizing pathogenic fungi in vitro and its secondary metabolites , 2010, The Journal of Microbiology.
[39] S. Pyne,et al. Sphingosine 1-phosphate and cancer , 2010, Nature Reviews Cancer.
[40] A. Thorner,et al. Mitochondrial HEP27 Is a c-Myb Target Gene That Inhibits Mdm2 and Stabilizes p53 , 2010, Molecular and Cellular Biology.
[41] B. Persson,et al. Medium- and short-chain dehydrogenase/reductase gene and protein families , 2008, Cellular and Molecular Life Sciences.
[42] Yoshihiro Yamanishi,et al. KEGG for linking genomes to life and the environment , 2007, Nucleic Acids Res..
[43] E. Maser,et al. Carbonyl Reductases and Pluripotent Hydroxysteroid Dehydrogenases of the Short-chain Dehydrogenase/reductase Superfamily , 2007, Drug metabolism reviews.
[44] Lin Fang,et al. WEGO: a web tool for plotting GO annotations , 2006, Nucleic Acids Res..
[45] H. Jörnvall,et al. Hep27, a member of the short-chain dehydrogenase/reductase family, is an NADPH-dependent dicarbonyl reductase expressed in vascular endothelial tissue , 2006, Cellular and Molecular Life Sciences CMLS.
[46] K. Ansari,et al. Effects of trichothecene mycotoxins on eukaryotic cells: A review , 2005, Food additives and contaminants.
[47] J. Ko,et al. Monochromosome transfer provides functional evidence for growth‐suppressive genes on chromosome 14 in nasopharyngeal carcinoma , 2003, Genes, chromosomes & cancer.
[48] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..
[49] S. Petersen,et al. Chromosomal imbalances of primary and metastatic lung adenocarcinomas , 2002, The Journal of pathology.
[50] P. D. Dal Cin,et al. Molecular cytogenetic definition of three distinct chromosome arm 14q deletion intervals in gastrointestinal stromal tumors , 2001, Genes, chromosomes & cancer.
[51] J. Kere,et al. Deletions at 14q in malignant mesothelioma detected by microsatellite marker analysis , 1999, British Journal of Cancer.
[52] A. Heguy,et al. A nuclear protein, synthesized in growth-arrested human hepatoblastoma cells, is a novel member of the short-chain alcohol dehydrogenase family. , 1995, European journal of biochemistry.
[53] M Krook,et al. Short-chain dehydrogenases/reductases (SDR). , 1995, Biochemistry.
[54] Pelayo Vilar,et al. Nasopharyngeal Carcinoma , 1966 .